TD Cowen analyst Phil Nadeau maintained a Buy rating on Neurocrine (NBIX – Research Report) today and set a price target of $165.00. The company’s shares opened today at $134.98. Discover top-rated ...
With no retired Supreme Court justices available to step in, the state's highest court randomly selected two retired superior court jurists to create a full bench to decide the appeal of the landmark ...